Sandoz Inaugurates New Antibiotic Production Plant in Austria and New Biosimilar Development Center in Germany

Investment of EUR 175 million reaffirms Sandoz commitment to long-term leadership in off-patent medicines New penicillin production process will significantly improve ecological footprint and help secure European-based supply Cutting-edge development hub will play key role in supporting long-term growth of leading biosimilar business Basel, November 10, 2023 (Korea Bizwire) – Sandoz, the global leader in generic [...]